Neoadjuvant Chemoradiotherapy for Oral Cavity Cancer: Predictive Factors for Response and Interim Analysis of the Prospective INVERT-Trial.
von der Grün J, Winkelmann R, Burck I, Martin D, Rödel F, Wild PJ, Bankov K, Weigert A, Kur IM, Brandts C, Filmann N, Issing C, Thönissen P, Tanneberger AM, Rödel C, Ghanaati S, Balermpas P.
von der Grün J, et al. Among authors: rodel c, rodel f.
Front Oncol. 2022 Mar 24;12:817692. doi: 10.3389/fonc.2022.817692. eCollection 2022.
Front Oncol. 2022.
PMID: 35402268
Free PMC article.